- A recent study has revealed that a number of Covid-19 patients have suffered from other conditions since being positive
- Many have faced neurological and psychiatric issues within six months of recovering from the virus
- The study also revealed that the most prominent conditions people were diagnosed with were anxiety and depression
In a study published on Wednesday in The Lancet Psychiatry Journal focused on studying the health records of over 230 000 patients who had recovered from Covid-19, it was discovered that 34% were diagnosed with a neurological or psychiatric condition within six months.
Researchers who conducted the study stated that it was not immediately clear how the virus is linked to both neurological and mental health conditions.
According to the researchers, anxiety and depression were the most common diagnoses among the 14 disorders that were evaluated. The study revealed anxiety to be the most common condition impacting 17% of patients.
A report published by IOL revealed that when compared to conditions with similar effects as Covid-19, the researchers discovered that there was a significant increase in the risk of neurological and mental health diagnoses in post-recovery patients.
The study stated that Covid-19 posed a 44% greater risk of neurological and mental health diagnoses compared to flu, and a 16% higher risk compared to respiratory tract infections.
SABC News emphasised that despite records of strokes, dementia and other neurological disorders being a rarer occurrence among Covid-19 survivors, researchers still stress the significance of the data, especially among people who went through severe Covid-19 cases.
Among those who were admitted into intensive care, 7% had a stroke within six months and just under 2% were diagnosed with dementia.
In other Covid-19 news, Briefly.co.za reported that an order was issued by the Gauteng High Court on Tuesday allowing for medicine that has Ivermectin as an active ingredient to be used to treat Covid-19 if prescribed by a doctor. The news follows a settlement that was reached between Afriforum and Dr George Coetzee.
The order of court was made by Judge Cassim Sardiwalla. Previously, the South African Health Products Regulatory Authority (Sahpra) and the aforementioned applicants made an agreement for the access to and compounding of Ivermectin.
Sahpra's registration of the medicine allows for it to be compounded and made accessible under Section 21 of the Medicines and Related Substances Act.
Enjoyed reading our story? Download BRIEFLY's news app on Google Play now and stay up-to-date with major South African news!